The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oxytocic Medicine Market Research Report 2024

Global Oxytocic Medicine Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1766179

No of Pages : 94

Synopsis
Oxytocic medicines, also known as uterotonic agents, are medications used to induce or augment labor and to control postpartum bleeding. These medications work by stimulating uterine contractions, helping the uterus to contract and relax effectively during childbirth or after delivery. Oxytocic medicines are commonly used in obstetrics and are administered under the supervision of healthcare professionals.

Global Oxytocic Medicine market is projected to reach US$ 230.2 million in 2029, increasing from US$ 157 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oxytocic Medicine market research.

Key companies engaged in the Oxytocic Medicine industry include Teva, Abbott, JHP Pharmaceuticals, Novartis, Baxter, Pfizer, Fresenius Kabi, Ferring and Dr. Reddy’s Laboratories, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % value of Oxytocic Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Oxytocic Medicine market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oxytocic Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Teva
  • Abbott
  • JHP Pharmaceuticals
  • Novartis
  • Baxter
  • Pfizer
  • Fresenius Kabi
  • Ferring
  • Dr. Reddy’s Laboratories
  • Granules Pharmaceuticals

Segment by Type

  • Oxytocin
  • Ergot Alkaloids
  • Prostaglandins
  • Carbetocin

Segment by Application

  • Hospitals
  • Specialized Clinics
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Oxytocic Medicine report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oxytocic Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oxytocin
1.2.3 Ergot Alkaloids
1.2.4 Prostaglandins
1.2.5 Carbetocin
1.3 Market by Application
1.3.1 Global Oxytocic Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oxytocic Medicine Market Perspective (2018-2029)
2.2 Oxytocic Medicine Growth Trends by Region
2.2.1 Global Oxytocic Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oxytocic Medicine Historic Market Size by Region (2018-2023)
2.2.3 Oxytocic Medicine Forecasted Market Size by Region (2024-2029)
2.3 Oxytocic Medicine Market Dynamics
2.3.1 Oxytocic Medicine Industry Trends
2.3.2 Oxytocic Medicine Market Drivers
2.3.3 Oxytocic Medicine Market Challenges
2.3.4 Oxytocic Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oxytocic Medicine Players by Revenue
3.1.1 Global Top Oxytocic Medicine Players by Revenue (2018-2023)
3.1.2 Global Oxytocic Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Oxytocic Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oxytocic Medicine Revenue
3.4 Global Oxytocic Medicine Market Concentration Ratio
3.4.1 Global Oxytocic Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oxytocic Medicine Revenue in 2022
3.5 Oxytocic Medicine Key Players Head office and Area Served
3.6 Key Players Oxytocic Medicine Product Solution and Service
3.7 Date of Enter into Oxytocic Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oxytocic Medicine Breakdown Data by Type
4.1 Global Oxytocic Medicine Historic Market Size by Type (2018-2023)
4.2 Global Oxytocic Medicine Forecasted Market Size by Type (2024-2029)
5 Oxytocic Medicine Breakdown Data by Application
5.1 Global Oxytocic Medicine Historic Market Size by Application (2018-2023)
5.2 Global Oxytocic Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oxytocic Medicine Market Size (2018-2029)
6.2 North America Oxytocic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oxytocic Medicine Market Size by Country (2018-2023)
6.4 North America Oxytocic Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oxytocic Medicine Market Size (2018-2029)
7.2 Europe Oxytocic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oxytocic Medicine Market Size by Country (2018-2023)
7.4 Europe Oxytocic Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oxytocic Medicine Market Size (2018-2029)
8.2 Asia-Pacific Oxytocic Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oxytocic Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Oxytocic Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oxytocic Medicine Market Size (2018-2029)
9.2 Latin America Oxytocic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oxytocic Medicine Market Size by Country (2018-2023)
9.4 Latin America Oxytocic Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oxytocic Medicine Market Size (2018-2029)
10.2 Middle East & Africa Oxytocic Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oxytocic Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Oxytocic Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Oxytocic Medicine Introduction
11.1.4 Teva Revenue in Oxytocic Medicine Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Oxytocic Medicine Introduction
11.2.4 Abbott Revenue in Oxytocic Medicine Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 JHP Pharmaceuticals
11.3.1 JHP Pharmaceuticals Company Detail
11.3.2 JHP Pharmaceuticals Business Overview
11.3.3 JHP Pharmaceuticals Oxytocic Medicine Introduction
11.3.4 JHP Pharmaceuticals Revenue in Oxytocic Medicine Business (2018-2023)
11.3.5 JHP Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Oxytocic Medicine Introduction
11.4.4 Novartis Revenue in Oxytocic Medicine Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Oxytocic Medicine Introduction
11.5.4 Baxter Revenue in Oxytocic Medicine Business (2018-2023)
11.5.5 Baxter Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Oxytocic Medicine Introduction
11.6.4 Pfizer Revenue in Oxytocic Medicine Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Fresenius Kabi
11.7.1 Fresenius Kabi Company Detail
11.7.2 Fresenius Kabi Business Overview
11.7.3 Fresenius Kabi Oxytocic Medicine Introduction
11.7.4 Fresenius Kabi Revenue in Oxytocic Medicine Business (2018-2023)
11.7.5 Fresenius Kabi Recent Development
11.8 Ferring
11.8.1 Ferring Company Detail
11.8.2 Ferring Business Overview
11.8.3 Ferring Oxytocic Medicine Introduction
11.8.4 Ferring Revenue in Oxytocic Medicine Business (2018-2023)
11.8.5 Ferring Recent Development
11.9 Dr. Reddy’s Laboratories
11.9.1 Dr. Reddy’s Laboratories Company Detail
11.9.2 Dr. Reddy’s Laboratories Business Overview
11.9.3 Dr. Reddy’s Laboratories Oxytocic Medicine Introduction
11.9.4 Dr. Reddy’s Laboratories Revenue in Oxytocic Medicine Business (2018-2023)
11.9.5 Dr. Reddy’s Laboratories Recent Development
11.10 Granules Pharmaceuticals
11.10.1 Granules Pharmaceuticals Company Detail
11.10.2 Granules Pharmaceuticals Business Overview
11.10.3 Granules Pharmaceuticals Oxytocic Medicine Introduction
11.10.4 Granules Pharmaceuticals Revenue in Oxytocic Medicine Business (2018-2023)
11.10.5 Granules Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’